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Data sources
Experimental phenotypic datasets
We made use of 5 different Saccharomyces cerevisiae phenotypic datasets. First, we used 2 lethal
phenotype datasets published by Giaever et al. [1] and Dudley et al. [2], and presented in the main
manuscript. Then, we investigated the environmental stress conditions tested by Giaever et al. [1] and
Dudley et al. [2], as well as an other, but less well-known, gene deletion set by Kastenmayer et al. [3].
Cellular organizational units
S. cerevisiae multi-protein complex co-membership was determined from GO [4, 5], MIPS [6], protein-
protein interactions data obtained from the IntAct database (http://www.ebi.ac.uk/intact/site) and
estimates from tandem affinity purification-mass spectrometry experiments (AP-MS) [7–11]. This re-
sulted in an estimated interactome of 398 curated multi-protein complexes from the online databases
(GO, MIPS, IntAct), and 549 multi-protein complexes estimated from the AP-MS experiments [12].
The curated complexes are named by their database ID. The estimated multi-protein complexes are
named using the prefix apComplex followed by the author and year of the experiment, and an arbitrary
identification number [12].
Pathways were extracted from the Kyoto Encyclopedia of Genes and Genomes, KEGG [13]. KEGG
contains 99 pathways specific to S. cerevisiae out of 918 referenced, corresponding to 1,205 unique genes
in which 332 are essential and 94 are haploinsufficient.
Mappings between yeast genes, GO categories, and KEGG pathways were obtained from the R
metadata package, YEAST , available from the Bioconductor Project (http://www.bioconductor.org).
Gene coverage
The genome of S. cerevisiae is not entirely annotated and only a small proportion of the genes are
covered by our interactome or the KEGG pathways (Table S1). As mentioned above, we can divide
our interactome in 2 subsets: the curated multi-protein complexes,i.e., annotated in the GO, MIPS or
IntAct databases, and the predicted multi-protein complexes, estimated from high throughput proteomic
experiments using the Bioconductor package apComplex [12]. The curated interactome currently counts
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1,629 genes and 398 multi-protein complexes. The whole interactome (curated and predicted multi-
protein complexes) is now composed of 947 multi-protein complexes and 1,803 genes (including 695
essential genes and 100 haploinsufficient genes).
Genes KEGG pathways Curated interactome Curated and Predicted interactome
Total ORFs 6609 1205 1629 1803
Essential 1101 332 587 695
Haploinsufficient 184 94 84 100
Table S1: Genes coverage. The first row of the table presents the total number of ORFs in S. cerevisiae
genome (charaterized, uncharaterized, and dubious) and their coverage in KEGG pathways and our
protein interactome (curated and predicted multi-protein complexes databases). The 2 following rows
show the representation of the essential, and haploinsufficient genes.
Protein complexes and phenotype
Lethal phenotypes
The following tables present the results of the Hypergeometric test applied on the essential genes
(Table S2) and the haploinsufficient genes (Table S3) using the global interactome (i.e., curated and
predicted multi-protein complexes). We note that only the GO and MIPS complexes are annotated and
have an description as the other are predicted complexes.
Complex Observed Expected Size Odds P-value Description
GO:0005732 42 21.59 56 5.03 1.98e−08 small nucleolar ribo...
GO:0005666 17 6.55 17 Inf 8.11e−08 DNA-directed RNA pol...
MIPS-410.30 16 6.17 16 Inf 2.13e−07 Pre-replication comp...
apCompGavin2002: 228 18 7.32 19 29.43 3.75e−07 -
GO:0005656 15 5.78 15 Inf 5.61e−07 pre-replicative comp...
MIPS-360 28 13.88 36 5.77 1.50e−06 Proteasome
MIPS-410.35 18 7.71 20 14.70 2.40e−06 Replication complex
apCompGavin2002: 231 18 7.71 20 14.70 2.40e−06 -
MIPS-510.120 13 5.01 13 Inf 3.87e−06 RNA polymerase III
apCompGavin2002: 224 14 5.78 15 22.76 1.43e−05 -
GO:0046540 22 10.79 28 6.00 1.63e−05 U4/U6 x U5 tri-snRNP...
apCompGavin2002: 203 11 4.24 11 Inf 2.66e−05 -
apCompGavin2002: 50 19 9.25 24 6.20 5.36e−05 -
apCompGavin2002: 12 16 7.32 19 8.68 5.50e−05 -
GO:0000172 10 3.85 10 Inf 6.96e−05 ribonuclease MRP com...
GO:0005847 13 5.78 15 10.54 1.70e−04 mRNA cleavage and po...
GO:0005669 13 5.78 15 10.54 1.70e−04 transcription factor...
MIPS-360.10.10 13 5.78 15 10.54 1.70e−04 20S proteasome
apCompGavin2002: 43 13 5.78 15 10.54 1.70e−04 -
GO:0005849 9 3.47 9 Inf 1.82e−04 mRNA cleavage factor...
GO:0005655 9 3.47 9 Inf 1.82e−04 nucleolar ribonuclea...
apCompGavin2002: 205 9 3.47 9 Inf 1.82e−04 -
Continued on next page
2
Complex Observed Expected Size Odds P-value Description
GO:0005681 22 11.95 31 3.99 2.29e−04 spliceosome
apCompGavin2002: 61 12 5.40 14 9.72 3.88e−04 -
apCompGavin2002: 229 12 5.40 14 9.72 3.88e−04 -
apCompKrogan2004: 39 12 5.40 14 9.72 3.88e−04 -
GO:0043614 8 3.08 8 Inf 4.75e−04 multi-eIF complex
GO:0000145 8 3.08 8 Inf 4.75e−04 exocyst
MIPS-130 8 3.08 8 Inf 4.75e−04 Chaperonine containi...
MIPS-410.20 8 3.08 8 Inf 4.75e−04 Replication initiati...
MIPS-440.12.20 8 3.08 8 Inf 4.75e−04 RNase MRP
apCompGavin2002: 71 8 3.08 8 Inf 4.75e−04 -
apCompGavin2002: 73 8 3.08 8 Inf 4.75e−04 -
apCompKrogan2004: 9 8 3.08 8 Inf 4.75e−04 -
apCompKrogan2004: 13 8 3.08 8 Inf 4.75e−04 -
apCompGavin2002: 250 10 4.24 11 16.16 5.00e−04 -
GO:0000177 9 3.85 10 14.52 1.19e−03 cytoplasmic exosome ...
GO:0005675 9 3.85 10 14.52 1.19e−03 holo TFIIH complex
apCompGavin2002: 53 9 3.85 10 14.52 1.19e−03 -
apCompGavin2002: 126 9 3.85 10 14.52 1.19e−03 -
apCompHo2002: 86 9 3.85 10 14.52 1.19e−03 -
GO:0019774 7 2.70 7 Inf 1.24e−03 proteasome core comp...
MIPS-160 7 2.70 7 Inf 1.24e−03 Exocyst complex
MIPS-440.12.10 7 2.70 7 Inf 1.24e−03 Exosome complex
apCompGavin2002: 52 7 2.70 7 Inf 1.24e−03 -
apCompGavin2002: 202 7 2.70 7 Inf 1.24e−03 -
apCompKrogan2004: 14 7 2.70 7 Inf 1.24e−03 -
apCompGavin2002: 14 12 5.78 15 6.47 1.26e−03 -
GO:0005665 10 4.63 12 8.07 1.96e−03 DNA-directed RNA pol...
apCompGavin2002: 200 10 4.63 12 8.07 1.96e−03 -
apCompGavin2002: 223 10 4.63 12 8.07 1.96e−03 -
apCompKrogan2004: 2 10 4.63 12 8.07 1.96e−03 -
apCompKrogan2004: 4 11 5.40 14 5.92 2.67e−03 -
apCompGavin2002: 181 18 10.41 27 3.25 2.69e−03 -
MIPS-510.180.10.30 8 3.47 9 12.89 2.82e−03 NEF3 complex
apCompKrogan2004: 61 8 3.47 9 12.89 2.82e−03 -
MCM2-7 heterohexamer 6 2.31 6 Inf 3.24e−03 -
Signal recognition particle 6 2.31 6 Inf 3.24e−03 -
GO:0000127 6 2.31 6 Inf 3.24e−03 transcription factor...
GO:0005664 6 2.31 6 Inf 3.24e−03 nuclear origin of re...
apCompGavin2002: 62 6 2.31 6 Inf 3.24e−03 -
apCompHo2002: 237 6 2.31 6 Inf 3.24e−03 -
apCompKrogan2004: 56 6 2.31 6 Inf 3.24e−03 -
apCompHo2002: 76 12 6.17 16 4.85 3.29e−03 -
apCompGavin2002: 158 13 6.94 18 4.20 3.79e−03 -
apCompGavin2002: 56 9 4.24 11 7.26 4.32e−03 -
apCompGavin2002: 217 9 4.24 11 7.26 4.32e−03 -
Continued on next page
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Complex Observed Expected Size Odds P-value Description
GO:0000176 10 5.01 13 5.38 5.57e−03 nuclear exosome (RNa...
MIPS-510.40.10 10 5.01 13 5.38 5.57e−03 RNA polymerase II
apCompGavin2002: 91 10 5.01 13 5.38 5.57e−03 -
apCompGavin2002: 209 10 5.01 13 5.38 5.57e−03 -
apCompHo2002: 21 11 5.78 15 4.44 6.55e−03 -
GO:0030915 7 3.08 8 11.26 6.60e−03 Smc5-Smc6 complex
apCompKrogan2004: 55 7 3.08 8 11.26 6.60e−03 -
apCompGavin2002: 42 12 6.55 17 3.88 7.29e−03 -
apCompGavin2002: 182 14 8.09 21 3.23 8.14e−03 -
DNA replication factor C complex 5 1.93 5 Inf 8.44e−03 -
GO:0000120 5 1.93 5 Inf 8.44e−03 RNA polymerase I tra...
GO:0000799 5 1.93 5 Inf 8.44e−03 nuclear condensin co...
GO:0042765 5 1.93 5 Inf 8.44e−03 GPI-anchor transamid...
GO:0032040 5 1.93 5 Inf 8.44e−03 small subunit proces...
MIPS-445.10 5 1.93 5 Inf 8.44e−03 SCF-CDC4 complex
apCompGavin2002: 51 5 1.93 5 Inf 8.44e−03 -
apCompGavin2002: 70 5 1.93 5 Inf 8.44e−03 -
apCompGavin2002: 99 5 1.93 5 Inf 8.44e−03 -
apCompGavin2002: 175 5 1.93 5 Inf 8.44e−03 -
apCompGavin2002: 194 5 1.93 5 Inf 8.44e−03 -
apCompGavin2002: 207 5 1.93 5 Inf 8.44e−03 -
apCompHo2002: 34 5 1.93 5 Inf 8.44e−03 -
apCompHo2002: 166 5 1.93 5 Inf 8.44e−03 -
apCompKrogan2004: 43 5 1.93 5 Inf 8.44e−03 -
apCompKrogan2004: 52 5 1.93 5 Inf 8.44e−03 -
apCompKrogan2004: 81 5 1.93 5 Inf 8.44e−03 -
GO:0008541 8 3.85 10 6.44 9.34e−03 proteasome regulator...
apCompGavin2002: 155 8 3.85 10 6.44 9.34e−03 -
apCompGavin2002: 196 8 3.85 10 6.44 9.34e−03 -
apCompGavin2002: 199 8 3.85 10 6.44 9.34e−03 -
apCompGavin2002: 204 8 3.85 10 6.44 9.34e−03 -
apCompGavin2002: 221 8 3.85 10 6.44 9.34e−03 -
apCompHo2002: 81 8 3.85 10 6.44 9.34e−03 -
apCompKrogan2004: 30 8 3.85 10 6.44 9.34e−03 -
apCompKrogan2004: 82 8 3.85 10 6.44 9.34e−03 -
Table S2: Essentiality can be attributed to some multi-protein complexes. These complexes (curated
and predicted) present an over-representation of essential genes(p-value<0.01). Observed: number of
essential genes in the complex; Expected: expected number of essential genes in the complex; Size:
total number of genes in the complex; Odds: odds ratios; P-value: p-value of the Hypergeometric test;
Description: fullname. Note that when the multi-protein complex is entirely composed of essential genes
(Observed = Size) the odds ratio are infinite (Inf).
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Observed Expected Size Odds P-value Description
MIPS-130 7 0.44 8 128.11 1.01e−08 Chaperonine containi...
GO:0005732 16 3.11 56 7.92 1.62e−08 small nucleolar ribo...
GO:0005832 7 0.61 11 31.97 3.61e−07 chaperonin-containin...
GO:0005665 7 0.67 12 25.56 8.28e−07 DNA-directed RNA pol...
MIPS-510.40.10 7 0.72 13 21.29 1.71e−06 RNA polymerase II
apCompGavin2002: 223 6 0.67 12 18.05 1.77e−05 -
GO:0000176 6 0.72 13 15.47 3.14e−05 nuclear exosome (RNa...
GO:0000177 5 0.55 10 17.87 9.60e−05 cytoplasmic exosome ...
apCompHo2002: 141 3 0.17 3 Inf 1.66e−04 -
MIPS-440.12.10 4 0.39 7 23.61 2.74e−04 Exosome complex
apCompGavin2002: 12 6 1.05 19 8.30 3.77e−04 -
apCompKrogan2004: 5 5 0.72 13 11.15 4.29e−04 -
MIPS-510.40 8 1.94 35 5.40 4.57e−04 RNA polymerase II ho...
apCompGavin2002: 181 7 1.50 27 6.33 4.64e−04 -
apCompKrogan2004: 10 4 0.44 8 17.70 5.25e−04 -
apCompKrogan2004: 22 4 0.44 8 17.70 5.25e−04 -
apCompGavin2002: 143 3 0.22 4 52.64 6.36e−04 -
apCompHo2002: 32 3 0.22 4 52.64 6.36e−04 -
apCompGavin2002: 49 5 0.78 14 9.91 6.37e−04 -
apCompGavin2002: 14 5 0.83 15 8.91 9.14e−04 -
apCompGavin2002: 79 5 0.83 15 8.91 9.14e−04 -
apCompGavin2002: 175 3 0.28 5 26.30 1.53e−03 -
apCompKrogan2004: 52 3 0.28 5 26.30 1.53e−03 -
apCompGavin2002: 42 5 0.94 17 7.42 1.72e−03 -
apCompKrogan2004: 2 4 0.67 12 8.83 3.13e−03 -
apCompGavin2002: 41 5 1.11 20 5.92 3.78e−03 -
MIPS-510.120 4 0.72 13 7.84 4.32e−03 RNA polymerase III
apCompKrogan2004: 74 3 0.39 7 13.14 4.92e−03 -
GO:0005736 4 0.78 14 7.05 5.80e−03 DNA-directed RNA pol...
GO:0043614 3 0.44 8 10.50 7.56e−03 multi-eIF complex
apCompKrogan2004: 13 3 0.44 8 10.50 7.56e−03 -
apCompGavin2002: 50 5 1.33 24 4.66 8.68e−03 -
GO:0005850 2 0.17 3 34.73 8.81e−03 eukaryotic translati...
GO:0000928 2 0.17 3 34.73 8.81e−03 gamma-tubulin small ...
apCompGavin2002: 251 2 0.17 3 34.73 8.81e−03 -
apCompHo2002: 44 2 0.17 3 34.73 8.81e−03 -
apCompHo2002: 118 2 0.17 3 34.73 8.81e−03 -
apCompHo2002: 205 2 0.17 3 34.73 8.81e−03 -
Table S3: Haploinsufficiency can be attributed to some multi-protein complexes. These complexes (cu-
rated and predicted) present an over-representation of haploinsufficient genes (p-value<0.01). Observed:
number of haploinsufficient genes in the complex; Expected: expected number of haploinsufficient genes
in the complex; Size: total number of genes in the complex; Odds: odds ratios; P-value: p-value of
the Hypergeometric test; Description: fullname. Note that when the multi-protein complex is entirely
composed of haploinsufficient genes (Observed = Size) the odds ratio are infinite (Inf).
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Kastenmayer et al. (2006) undertook the first functional studies of small open reading frames
(sORFs), using S. cerevisiae as a model. Phenotypic analyses of the new gene-deletion strains identified
22 sORFs required for haploid growth, growth at high temperature, growth in the presence of a non-
fermentable carbon source, or growth in the presence of DNA damage and replication-arrest agents. We
looked if those 22 sORFs are randomly distributed among protein complexes or if they cluster within
a set of them. We identified 11 critical complexes with an over-representation of sORFs (listed below).
As observed by Kastenmayer et al. (2006), the sORFs are well conserved across species compare to
the other genes that compose the protein complexes (Figure S1). We also note that 6 of the identified
complexes were also found in our analysis of the essential genes.
---------Condition: sORF -----------
GO:0046540 U4/U6 x U5 tri-snRNP complex
GO:0042729 DASH complex
GO:0005732 small nucleolar ribonucleoprotein complex
MIPS-270.20.30 Dam1 protein complex
GO:0000776 kinetochore
MIPS-270.20 Outer Kinetochor Protein Complex
GO:0005665 DNA-directed RNA polymerase II, core complex
MIPS-510.40.10 RNA polymerase II
MIPS-510.120 RNA polymerase III
GO:0005736 DNA-directed RNA polymerase I complex
GO:0005666 DNA-directed RNA polymerase III complex
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Figure S1: sORFs from critical complexes are highly conserved across species. Each panel presents a
comparison between S. cerevisiae and one other species (named in the panel strip). In each panel, each
boxplot shows the distribution of the gene evolution distances between the 2 species, calculated using
the RSD approach [14]. The ’S’ boxplot represents the distribution of distances for the genes inducing
a lethal phenotype (Sensitive) and the ’O’ represents the other set of genes. In all cases the median
distance and the spread (IQR) are smaller for the sORFs.
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Environmental stress conditions and fitness growth defect phenotypes
While our approach focuses on understanding the functional roles that underly lethal phenotypes in
rich media, these methods can also be used to investigate other environmental conditions or other phe-
notypic changes. As an example, using the curated subset of our interactome, we looked at phenotypic
datasets by Giaever et al. [1] and Dudley et al. [2] where they measured fitness growth defects in various
environmental stress conditions.
Giaever et al. (2002)
As a first intention, we used the same filtering parameters as described in Giaever et al. [1] to select
genes that present a significant growth defect according to the condition and generation time under
study.
Table S4 resumes our results and shows that some but not all experimental conditions give rise to
phenotype that can be attributed to some multi-protein complexes. In reality, we can not rule out
the fact the phenotype originated from the other experimental conditions are not associated to any
multi-protein complexes as our view and coverage of the S. cerevisae interactome is incomplete.
Giaever et al. (2002) Interactome p.value Complexes
pH8g15 225 41 0 10
pH8g5 275 54 0.002 9
nystatin15 46 8 0.006 3
ypg15 30 3 0.009 1
nystatin5 171 37 0.016 -
minimalPlus15 93 14 0.034 -
ypg5 23 6 0.036 -
minimalC5 183 27 0.162 -
trpM5 343 49 0.166 -
sorbitol15 59 6 0.21 -
NaCl15 334 47 0.269 -
sorbitol5 356 48 0.283 -
lysM5 304 36 0.286 -
NaCl5 175 22 0.345 -
minimalPlus5 262 33 0.86 -
Table S4: Some phenotypic changes induced in environmental stress conditions (Giaever et al. 2002) are
tightly associated with multi-protein complexes. Each row corresponds to an environmental stress condition
and different generation time (5, 15). The first column indicates the number of mutants with growth defect
in Giaever’s experiment. The second columns indicates the number of those deleted genes in the interactome.
The third columns presents the p-value obtained by the graph theory test. A p-value < 0.01 indicates that
those deleted genes are not randomly distributed in the multi-protein complexes of the interactome. The
fourth column indicates the number of multi-protein complexes involved. The differents conditions are: ypg:
yeast/peptone/galactose 5 gen. rep. a and b; sorbitol: 1.5M Sorbitol (sugar, osmotic stress); NaCl: 1M NaCl
(salt, osmotic stress); lysM: lysine minus (lack of required AA); thM: threonine minus (lack of required AA);
trpM: tritophanee minus (lack of required AA); minimalPlus: minimal + histidine/leuvine/uracile; minimalC:
minimal complete; nystatin: Nystatin (antifungal drug); pH8: pH 8 (alkali stress).
The following list shows the different multi-protein complexes involved in the different experimental
conditions.
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---------Condition: nystatin15 -----------
GO:0000813 ESCRT I complex
MIPS-260.70 Vps4p ATPase complex (Vps protein complex)
GO:0000815 ESCRT III complex
---------Condition: pH8g15 -----------
MIPS-260.20 Clathrin-associated protein (AP) complex
GO:0030122 AP-2 adaptor complex
GO:0030121 AP-1 adaptor complex
GO:0005955 calcineurin complex
GO:0030123 AP-3 adaptor complex
MIPS-260.20.10 AP-1 complex
EBI-1249909 Calcineurin variant 1
GO:0048188 COMPASS complex
MIPS-140.30.30.30 Dynactin complex
GO:0005869 dynactin complex
---------Condition: pH8g5 -----------
MIPS-260.20 Clathrin-associated protein (AP) complex
GO:0000812 SWR1 complex
GO:0005955 calcineurin complex
GO:0030123 AP-3 adaptor complex
GO:0030121 AP-1 adaptor complex
EBI-1249909 Calcineurin variant 1
GO:0016593 Cdc73/Paf1 complex
GO:0030122 AP-2 adaptor complex
MIPS-260.20.10 AP-1 complex
---------Condition: ypg15 -----------
MIPS-510.190.80 GAL80 complex
Under nystatin condition, we identify or example the three ESCRT complexes or Endosomal Sorting
Complexes Required for Transport (GO:0000813, GO:0000814, GO:0000815 ) as significantly related
to the growth defect. At pH8, one of the interesting complex seems to be the Gene Ontology complex
GO:0000812 or SWR1 complex, composed of 13 genes. It is a multi-subunit protein complex that is
involved in chromatin remodeling. It is required for the incorporation of the histone variant H2AZ
into chromatin. In S. cerevisiae, the complex contains Swr1p, a Swi2/Snf2-related ATPase, and 12
additional subunits.
As described in the main manuscript, we completed our analysis by testing the conservation level
of the genes inducing those phenotypes and over-represented in some, thus critical, multi-protein com-
plexes. We tested whether in a protein complex, genes inducing the observed phenotype are more
conserved than the other genes of the complex. Figure S2 shows that it might be the case in some of
the environmental conditions.
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Figure S2: Non-essential genes inducing fitness growth defect phenotype under the stress conditions
studied by Giaever et al. (2002) and over-represented in some, thus critical, complexes seems well
conserved across species. Each panel presents a comparison between S. cerevisiae and one other species
(named in the panel strip). In each panel, each boxplot shows the distribution of the gene evolution
distances between the 2 species, calculated using the RSD approach [14]. The ’S’ boxplot represents
the distribution of distances for the genes inducing a lethal or growth defect phenotype (Sensitive) and
the ’O’ represents the other set of genes. In many cases the median distance and the spread (IQR) are
smaller for the sensitive genes.
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Dudley et. al (2005)
Dudley et al. [2] created a collection of gene-deletion mutants to determine genes that contribute to a
particular phenotype in 21 different environmental conditions. Table S6 shows the results of the graph
theory approach and the Hypergeometric test applied to each of the condition. The first two columns
indicates the number of genes that were identified as sensitive by Dudley et al. [2] and how many of
those genes are actually present in our interactome. The p-value column correspond to the result of the
graph theory approach. A p-value ≤ 0.01 in a row shows that in that condition the sensitive genes are
not randomly distributed among multi-protein complexes. Finally, the number of complexes involved
in the phenotypic changes are listed in the last column.
Dudley et al (2005) Interactome p.value Complexes
CaCl2 180 73 0 14
CAD 83 36 0 15
cyclohex 164 62 0 20
FeLim 35 15 0 3
HU 87 46 0 11
MPA 11 5 0 5
Paraq 36 21 0 7
YPGal 41 15 0 7
YPGly 206 53 0 16
YPRaff 31 13 0 4
YPLac 159 33 0.001 8
UV 32 19 0.006 5
HygroB 264 85 0.007 16
lowPO4 34 6 0.015 -
pH3 16 4 0.016 -
rap 119 39 0.016 -
EtOH 75 43 0.018 -
NaCl 57 23 0.133 -
Caff 208 90 0.22 -
benomyl 34 15 0.465 -
Sorb 8 - - -
Table S5: Dudley et al. (2005) environmental stress conditions. Each row corresponds an environmental stress
condition. The first column indicates the number of mutants with growth defect in Dudley’s experiment. The
second column indicates the number of those deleted genes in the interactome. The third column presents
the p-value obtained by the graph theory test. A p-value <= 0.01 indicates that those deleted genes are
not randomly distributed in the multi-protein complexes of the interactome. The fourth column indicates the
number of multi-protein complexes involved. The 22 environmental conditions listed are: benomyl: 15ug/ml
benomyl,microtubule function; CaCl2: 0.7M calcium chloride, divalent cation; CAD: 55uM Cadmium, heavy
metal; Caff: 2mg/ml Caffeine; cyclohex: 0.18ug/ml cycloheximide, protein synthesis; DTT: unknown; EtOH
YPD + 6% Ethanol; FeLim: irion limited,nutrient limited condition; HU: 11.4mg/ml Hudroxyurea, DNA
replication and repair; HygroB: 50ug/ml hygromycin B, aminoglycosides; lowPO4: low phosphate, nutrient
limited condition; MPA: 20ug/ml mycophenolic acid, transcriptional elongation; NaCl: 1.2M sodium chloride,
general stress condition; Paraq: 1mM paraquat, oxidative stress; pH3: low pH, general stress condition; rap:
0.1ug/ml rapamycin, protein synthesis; Sorb: 1.2M sorbitol, general stress condition; UV: 100J/m2 ultra-violet,
DNA replication and repair; YPGal 2% galactose, carbon source; YPGly 3% glycerol, carbon source; YPLac
2% lactate, carbon source; YPRaff 2% raffinose, carbon source.
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---------Condition: CaCl2 -----------
MIPS-220 H+-transporting ATPase, vacuolar
GO:0000815 ESCRT III complex
GO:0000814 ESCRT II complex
MIPS-260.70 Vps4p ATPase complex (Vps protein complex)
GO:0016593 Cdc73/Paf1 complex
GO:0000221 vacuolar proton-transporting V-type ATPase, V1 domain
GO:0000938 GARP complex
GO:0008023 transcription elongation factor complex
GO:0030897 HOPS complex
MIPS-90.20 Vacuolar assembly complex
MIPS-90.30 ER assembly complex
GO:0000220 vacuolar proton-transporting V-type ATPase, V0 domain
MIPS-510.40 RNA polymerase II holoenzyme
MIPS-510.190.50 SWI/SNF transcription activator complex
---------Condition: CAD -----------
GO:0000815 ESCRT III complex
MIPS-260.70 Vps4p ATPase complex (Vps protein complex)
GO:0000938 GARP complex
GO:0030904 retromer complex
GO:0030897 HOPS complex
MIPS-230.20.10 ADA complex
MIPS-90.20 Vacuolar assembly complex
MIPS-260.30.30.10 Vps35/Vps29/Vps26 complex
EBI-1250344
GO:0005838 proteasome regulatory particle (sensu Eukaryota)
GO:0005671 Ada2/Gcn5/Ada3 transcription activator complex
GO:0046695 SLIK (SAGA-like) complex
MIPS-230.20.20 SAGA complex
GO:0033263 CORVET complex
EBI-1251060
---------Condition: cyclohex -----------
MIPS-230.20.10 ADA complex
GO:0000508 Rpd3L complex
GO:0000119 mediator complex
GO:0016593 Cdc73/Paf1 complex
EBI-1250344
GO:0046695 SLIK (SAGA-like) complex
MIPS-230.20.20 SAGA complex
GO:0005671 Ada2/Gcn5/Ada3 transcription activator complex
EBI-1251060
MIPS-510.40.20 Kornberg's mediator (SRB) complex
MIPS-90.30 ER assembly complex
MIPS-370 Protein N-acetyltransferase
MIPS-510.40 RNA polymerase II holoenzyme
GO:0000220 vacuolar proton-transporting V-type ATPase, V0 domain
MIPS-220 H+-transporting ATPase, vacuolar
GO:0031415 NatA complex
MIPS-510.190.50 SWI/SNF transcription activator complex
GO:0000445 THO complex part of transcription export complex
GO:0005838 proteasome regulatory particle (sensu Eukaryota)
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GO:0016514 SWI/SNF complex
---------Condition: FeLim -----------
MIPS-220 H+-transporting ATPase, vacuolar
GO:0000220 vacuolar proton-transporting V-type ATPase, V0 domain
GO:0000221 vacuolar proton-transporting V-type ATPase, V1 domain
---------Condition: HU -----------
MIPS-510.40 RNA polymerase II holoenzyme
GO:0000119 mediator complex
MIPS-510.40.20 Kornberg's mediator (SRB) complex
GO:0016593 Cdc73/Paf1 complex
GO:0033062 Rhp55-Rhp57 complex
MIPS-510.190.50 SWI/SNF transcription activator complex
MIPS-260.70 Vps4p ATPase complex (Vps protein complex)
GO:0016514 SWI/SNF complex
GO:0000445 THO complex part of transcription export complex
GO:0000815 ESCRT III complex
GO:0031207 Sec62/Sec63 complex
---------Condition: MPA -----------
MIPS-230.20.20 SAGA complex
EBI-1251060
GO:0046695 SLIK (SAGA-like) complex
MIPS-370 Protein N-acetyltransferase
GO:0031415 NatA complex
---------Condition: Paraq -----------
MIPS-220 H+-transporting ATPase, vacuolar
GO:0000220 vacuolar proton-transporting V-type ATPase, V0 domain
GO:0000814 ESCRT II complex
GO:0000221 vacuolar proton-transporting V-type ATPase, V1 domain
MIPS-90.30 ER assembly complex
GO:0000813 ESCRT I complex
GO:0000815 ESCRT III complex
---------Condition: YPGal -----------
MIPS-220 H+-transporting ATPase, vacuolar
MIPS-510.190.80 GAL80 complex
GO:0000119 mediator complex
MIPS-510.40.20 Kornberg's mediator (SRB) complex
GO:0000220 vacuolar proton-transporting V-type ATPase, V0 domain
GO:0000221 vacuolar proton-transporting V-type ATPase, V1 domain
MIPS-510.40 RNA polymerase II holoenzyme
---------Condition: YPGly -----------
MIPS-220 H+-transporting ATPase, vacuolar
GO:0009353 mitochondrial oxoglutarate dehydrogenase complex
GO:0016602 CCAAT-binding factor complex
EBI-1225194
MIPS-420.50 F0/F1 ATP synthase (complex V)
MIPS-230.20.10 ADA complex
GO:0000220 vacuolar proton-transporting V-type ATPase, V0 domain
GO:0005754 mitochondrial proton-transporting ATP synthase, catalytic core
MIPS-90.30 ER assembly complex
MIPS-440.40.10 mitochondrial 3'-to-5' exoribonuclease (mtEXO)
GO:0000221 vacuolar proton-transporting V-type ATPase, V1 domain
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MIPS-420.40 Cytochrome c oxidase (complex IV)
GO:0005751 mitochondrial respiratory chain complex IV
EBI-1250344
GO:0005671 Ada2/Gcn5/Ada3 transcription activator complex
GO:0005967 mitochondrial pyruvate dehydrogenase complex
---------Condition: YPRaff -----------
MIPS-220 H+-transporting ATPase, vacuolar
GO:0000220 vacuolar proton-transporting V-type ATPase, V0 domain
MIPS-90.30 ER assembly complex
GO:0000221 vacuolar proton-transporting V-type ATPase, V1 domain
---------Condition: YPLac -----------
GO:0009353 mitochondrial oxoglutarate dehydrogenase complex
EBI-1225194
GO:0016602 CCAAT-binding factor complex
MIPS-220 H+-transporting ATPase, vacuolar
GO:0000220 vacuolar proton-transporting V-type ATPase, V0 domain
MIPS-420.50 F0/F1 ATP synthase (complex V)
MIPS-440.40.10 mitochondrial 3'-to-5' exoribonuclease (mtEXO)
EBI-1225074
---------Condition: UV -----------
MIPS-510.180.10 Nucleotide excision repairosome
GO:0000110 nucleotide-excision repair factor 1 complex
GO:0000445 THO complex part of transcription export complex
GO:0000108 repairosome
GO:0000502 proteasome complex (sensu Eukaryota)
---------Condition: HygroB -----------
MIPS-260.20 Clathrin-associated protein (AP) complex
GO:0000815 ESCRT III complex
GO:0000814 ESCRT II complex
MIPS-260.70 Vps4p ATPase complex (Vps protein complex)
GO:0017119 Golgi transport complex
GO:0000938 GARP complex
GO:0031902 late endosome membrane
GO:0000136 alpha-1,6-mannosyltransferase complex
GO:0030897 HOPS complex
GO:0031416 NatB complex
MIPS-90.20 Vacuolar assembly complex
MIPS-90.30 ER assembly complex
GO:0000119 mediator complex
GO:0016593 Cdc73/Paf1 complex
GO:0031417 NatC complex
GO:0043529 GET complex
We note that some of the multi-protein complexes involved in phenotypic changes induced by the
anti-fungal drug Paraquat are similar to the one found for the anti-fungal drug Nystatin tested by
Giaever et al. (2002).
Similar to the previous analysis, Figure S3 presents the results of the evolution analysis. According
to those results, the genes inducing the phenotypes and over-represented in the critical complexes are
not evolutionary different to the other genes of the complexes.
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Figure S3: Non-essential genes inducing fitness growth defect phenotype under the stress conditions
studied by Dudley et al. (2005) and over-represented in some, thus critical, complexes do not seem
especially more conserved across species. Each panel presents a comparison between S. cerevisiae and
one other species (named in the panel strip). In each panel, each boxplot shows the distribution of
the gene evolution distances between the 2 species, calculated using the RSD approach [14]. The ’S’
boxplot represents the distribution of distances for the genes inducing a fitness growth defect phenotype
(Sensitive) and the ’O’ represents the other set of genes.
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Predicted multi-protein complexes
One way to assess the quality of the predicted multi-protein complexes is to search whether those
complexes are involved in multiple phenotypic changes as we have shown that in the case of essentiality
and haploinsufficiency several known complexes contribute to both phenotypes. Table S6 shows that
indeed 17 predicted multi-protein complexes can be attributed to at least 2 phenotypes.
cyclohex FeLim Paraq YPRaff HU YPGal MPA YPGly CaCl2 pH8g15 pH8g5 Ess HI
PC1 X X
PC2 X X
PC3 X X X X X X
PC4 X X X
PC5 X X
PC6 X X
PC7 X X
PC8 X X
PC9 X X
PC10 X X
PC11 X X
PC12 X X
PC13 X X
PC14 X X
PC15 X X
PC16 X X
PC17 X X
Table S6: Predicted multi-protein complexes contributing to more than one phenotype. Rows are predicted
multi-protein complexes and columns indicates the enviromnental conditions. The ’X’ marks when a partic-
ular multi-protein complexes is involved. The first 9 conditions were studied by Dudley et al. (2005) (cyclo-
hex: 0.18ug/ml cycloheximide, protein synthesis; FeLim: irion limited,nutrient limited condition; Paraq: 1mM
paraquat, oxidative stress; YPRaff: 2HU: 11.4mg/ml Hudroxyurea, DNA replication and repair; YPGal: 2MPA:
20ug/ml mycophenolic acid, transcriptional elongation; YPGly 3CaCl2: 0.7M calcium chloride, divalent cation).
The next two conditions were tested by Giaever et al. (2002) (pH8: pH 8 (alkali stress) after 5 and 15 generations;
ESS: essentiality). The last column is an experiment by Deutschbauer et al. (2005), HI: haploinsufficiency.
Complex ID Gene Commun Name Current Gene Annotation
PC1 - apCompGavin2002: 5
YDL040C NAT1 Subunit of the N-terminal acetyltransfer...
YHR013C ARD1 Subunit of the N-terminal acetyltransfer...
YMR116C ASC1 G-beta protein for Gpa2p; involved in tr...
PC2 - apCompKrogan2004: 18
YDR378C LSM6 Lsm (Like Sm) protein; part of heterohep...
YJL124C LSM1 Lsm (Like Sm) protein; forms heterohepta...
YGR054W Eukaryotic initiation factor (eIF) 2A; a...
YCR077C PAT1 Topoisomerase II-associated deadenylatio...
YGL173C KEM1 Evolutionarily-conserved 5’-3’ exonuclea...
PC3 - apCompHo2002: 31 YCR009C RVS161 Amphiphysin-like lipid raft protein; sub...YDR388W RVS167 Actin-associated protein, subunit of a c...
PC4 - apCompKrogan2004: 1
YBR279W PAF1 RNAP II-associated protein; defines larg...
YGL244W RTF1 Subunit of the RNA polymerase II-associa...
YLR418C CDC73 Constituent of Paf1 complex with RNA pol...
YOL145C CTR9 Component of the Paf1p complex, which is...
YOR123C LEO1 Component of the Paf1 complex, which ass...
Continued on next page
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Complex ID Gene Commun Name Current Gene Annotation
YGL207W SPT16 Subunit of the heterodimeric FACT comple...
YML069W POB3 Subunit of the heterodimeric FACT comple...
PC5 - apCompGavin2002: 6
YGR090W UTP22 Possible U3 snoRNP protein involved in m...
YHR013C ARD1 Subunit of the N-terminal acetyltransfer...
YMR116C ASC1 G-beta protein for Gpa2p; involved in tr...
PC6 - apCompGavin2002: 256
YEL051W VMA8 Subunit D of the eight-subunit V1 periph...
YGR020C VMA7 Subunit F of the eight-subunit V1 periph...
YKL080W VMA5 Subunit C of the eight-subunit V1 periph...
YOR332W VMA4 Subunit E of the eight-subunit V1 periph...
YPR036W VMA13 Subunit H of the eight-subunit V1 periph...
YKR001C VPS1 Dynamin-like GTPase required for vacuola...
PC7 - apCompGavin2002: 3
YBR288C APM3 Mu3-like subunit of the clathrin associa...
YGR261C APL6 Beta3-like subunit of the yeast AP-3 com...
YPL195W APL5 Delta adaptin-like subunit of the clathr...
PC8 - apCompGavin2002: 50
YPR023C EAF3 Esa1p-associated factor, nonessential co...
YDL014W NOP1 Nucleolar protein, component of the smal...
YDR324C UTP4 Nucleolar protein, component of the smal...
YHR052W CIC1 Essential protein that interacts with pr...
YBR095C RXT2 Subunit of the histone deacetylase Rpd3L...
YGR134W CAF130 Part of the evolutionarily-conserved CCR...
YLR002C NOC3 Protein that forms a nuclear complex wit...
YNL030W HHF2 One of two identical histone H4 proteins...
YLR249W YEF3 Translational elongation factor 3, stimu...
YPL012W RRP12 Protein required for export of the ribos...
YPR016C TIF6 Constituent of 66S pre-ribosomal particl...
YKR081C RPF2 Essential protein involved in the proces...
YNL110C NOP15 Constituent of 66S pre-ribosomal particl...
YLR276C DBP9 ATP-dependent RNA helicase of the DEAD-b...
YGL171W ROK1 ATP-dependent RNA helicase of the DEAD b...
YFL002C SPB4 Putative ATP-dependent RNA helicase, nuc...
YER006W NUG1 GTPase that associates with nuclear 60S ...
YGL111W NSA1 Constituent of 66S pre-ribosomal particl...
YGR103W NOP7 Nucleolar protein involved in rRNA proce...
YHR197W RIX1 Essential component of the Rix1 complex ...
YLR106C MDN1 Huge dynein-related AAA-type ATPase (mid...
YNL182C IPI3 Essential component of the Rix1 complex ...
YNR053C NOG2 Putative GTPase that associates with pre...
YOR272W YTM1 Constituent of 66S pre-ribosomal particl...
PC9 - apCompGavin2002: 12
YGR158C MTR3 3’5’ exoribonuclease, exosome subunit; n...
YDL014W NOP1 Nucleolar protein, component of the smal...
YDR324C UTP4 Nucleolar protein, component of the smal...
YHR052W CIC1 Essential protein that interacts with pr...
YOR206W NOC2 Protein that forms a nucleolar complex w...
YNL030W HHF2 One of two identical histone H4 proteins...
YLR074C BUD20 Protein involved in bud-site selection; ...
Continued on next page
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PC9 - apCompGavin2002: 12
YPR016C TIF6 Constituent of 66S pre-ribosomal particl...
YER126C NSA2 Protein constituent of 66S pre-ribosomal...
YGR245C SDA1 Highly conserved nuclear protein require...
YKR081C RPF2 Essential protein involved in the proces...
YNL110C NOP15 Constituent of 66S pre-ribosomal particl...
YGL171W ROK1 ATP-dependent RNA helicase of the DEAD b...
YER006W NUG1 GTPase that associates with nuclear 60S ...
YGR103W NOP7 Nucleolar protein involved in rRNA proce...
YHR197W RIX1 Essential component of the Rix1 complex ...
YLR106C MDN1 Huge dynein-related AAA-type ATPase (mid...
YNL182C IPI3 Essential component of the Rix1 complex ...
YNR053C NOG2 Putative GTPase that associates with pre...
PC10 - apCompKrogan2004: 13
YDR324C UTP4 Nucleolar protein, component of the smal...
YDR398W UTP5 Nucleolar protein, component of the smal...
YGR128C UTP8 Nucleolar protein required for export of...
YHR196W UTP9 Nucleolar protein, component of the smal...
YJL109C UTP10 Nucleolar protein, component of the smal...
YMR093W UTP15 Nucleolar protein, component of the smal...
YPL126W NAN1 U3 snoRNP protein, component of the smal...
YEL055C POL5 DNA Polymerase phi; has sequence similar...
PC11 - apCompGavin2002: 14
YGR158C MTR3 3’5’ exoribonuclease, exosome subunit; n...
YDL014W NOP1 Nucleolar protein, component of the smal...
YDR324C UTP4 Nucleolar protein, component of the smal...
YHR052W CIC1 Essential protein that interacts with pr...
YLR074C BUD20 Protein involved in bud-site selection; ...
YPR016C TIF6 Constituent of 66S pre-ribosomal particl...
YFR001W LOC1 Nuclear protein involved in asymmetric l...
YGL171W ROK1 ATP-dependent RNA helicase of the DEAD b...
YER006W NUG1 GTPase that associates with nuclear 60S ...
YGR103W NOP7 Nucleolar protein involved in rRNA proce...
YHR085W IPI1 Essential component of the Rix1 complex ...
YHR197W RIX1 Essential component of the Rix1 complex ...
YLR106C MDN1 Huge dynein-related AAA-type ATPase (mid...
YNL182C IPI3 Essential component of the Rix1 complex ...
YNR053C NOG2 Putative GTPase that associates with pre...
PC12 - apCompGavin2002: 223
YBR154C RPB5 RNA polymerase subunit ABC27, common to ...
YOR224C RPB8 RNA polymerase subunit ABC14.5, common t...
YPR187W RPO26 RNA polymerase subunit ABC23, common to ...
YMR146C TIF34 Subunit of the core complex of translati...
YDR404C RPB7 RNA polymerase II subunit B16; forms two...
YGL070C RPB9 RNA polymerase II subunit B12.6; contact...
YIL021W RPB3 RNA polymerase II third largest subunit ...
YJL140W RPB4 RNA polymerase II subunit B32; forms two...
YOR151C RPB2 RNA polymerase II second largest subunit...
YDR045C RPC11 RNA polymerase III subunit C11; mediates...
Continued on next page
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YGR005C TFG2 TFIIF (Transcription Factor II) middle s...
YDL166C FAP7 Essential NTPase required for small ribo...
PC13 - apCompKrogan2004: 2
YCR052W RSC6 Component of the RSC chromatin remodelin...
YDR303C RSC3 Component of the RSC chromatin remodelin...
YFR037C RSC8 Component of the RSC chromatin remodelin...
YIL126W STH1 ATPase component of the RSC chromatin re...
YKR008W RSC4 Component of the RSC chromatin remodelin...
YLR033W RSC58 Component of the RSC chromatin remodelin...
YLR321C SFH1 Component of the RSC chromatin remodelin...
YLR357W RSC2 Component of the RSC chromatin remodelin...
YML127W RSC9 Component of the RSC chromatin remodelin...
YMR033W ARP9 Component of both the SWI/SNF and RSC ch...
YMR091C NPL6 Component of the RSC chromatin remodelin...
YPR034W ARP7 Component of both the SWI/SNF and RSC ch...
PC14 - apCompGavin2002: 181
YOL148C SPT20 Subunit of the SAGA transcriptional regu...
YHR069C RRP4 3’-5’ exoribonuclease involved in rRNA p...
YPR023C EAF3 Esa1p-associated factor, nonessential co...
YOL051W GAL11 Subunit of the RNA polymerase II mediato...
YDL014W NOP1 Nucleolar protein, component of the smal...
YDR324C UTP4 Nucleolar protein, component of the smal...
YHL030W ECM29 Major component of the proteasome; tethe...
YHR052W CIC1 Essential protein that interacts with pr...
YGR134W CAF130 Part of the evolutionarily-conserved CCR...
YOR206W NOC2 Protein that forms a nucleolar complex w...
YLR002C NOC3 Protein that forms a nuclear complex wit...
YNL030W HHF2 One of two identical histone H4 proteins...
YLR249W YEF3 Translational elongation factor 3, stimu...
YDL160C DHH1 Cytoplasmic DExD/H-box helicase, stimula...
YNL061W NOP2 Probable RNA m(5)C methyltransferase, es...
YKR081C RPF2 Essential protein involved in the proces...
YLR276C DBP9 ATP-dependent RNA helicase of the DEAD-b...
YPL093W NOG1 Putative GTPase that associates with fre...
YGL171W ROK1 ATP-dependent RNA helicase of the DEAD b...
YFL002C SPB4 Putative ATP-dependent RNA helicase, nuc...
YER006W NUG1 GTPase that associates with nuclear 60S ...
YER139C Putative protein of unknown function; YE...
YGL111W NSA1 Constituent of 66S pre-ribosomal particl...
YGR103W NOP7 Nucleolar protein involved in rRNA proce...
YHR197W RIX1 Essential component of the Rix1 complex ...
YNR053C NOG2 Putative GTPase that associates with pre...
YOR272W YTM1 Constituent of 66S pre-ribosomal particl...
PC15 - apCompGavin2002: 42
YHR052W CIC1 Essential protein that interacts with pr...
YGR134W CAF130 Part of the evolutionarily-conserved CCR...
YDR060W MAK21 Constituent of 66S pre-ribosomal particl...
YOR206W NOC2 Protein that forms a nucleolar complex w...
Continued on next page
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PC15 - apCompGavin2002: 42
YNL030W HHF2 One of two identical histone H4 proteins...
YDL160C DHH1 Cytoplasmic DExD/H-box helicase, stimula...
YPR016C TIF6 Constituent of 66S pre-ribosomal particl...
YMR049C ERB1 Protein required for maturation of the 2...
YNL061W NOP2 Probable RNA m(5)C methyltransferase, es...
YHR066W SSF1 Constituent of 66S pre-ribosomal particl...
YKR081C RPF2 Essential protein involved in the proces...
YNL110C NOP15 Constituent of 66S pre-ribosomal particl...
YPL093W NOG1 Putative GTPase that associates with fre...
YGL171W ROK1 ATP-dependent RNA helicase of the DEAD b...
YGL111W NSA1 Constituent of 66S pre-ribosomal particl...
YGR103W NOP7 Nucleolar protein involved in rRNA proce...
YOR272W YTM1 Constituent of 66S pre-ribosomal particl...
PC16 - apCompGavin2002: 175
YCR035C RRP43 Protein involved in rRNA processing; com...
YGR095C RRP46 Protein involved in rRNA processing; com...
YGR195W SKI6 3’-to-5’ phosphorolytic exoribonuclease ...
YPR137W RRP9 Protein involved in pre-rRNA processing,...
YOR326W MYO2 One of two type V myosin motors (along w...
PC17 - apCompKrogan2004: 52
YCR057C PWP2 Conserved 90S pre-ribosomal component es...
YDR449C UTP6 Nucleolar protein, component of the smal...
YJL069C UTP18 Possible U3 snoRNP protein involved in m...
YLR222C UTP13 Nucleolar protein, component of the smal...
YLR409C UTP21 Possible U3 snoRNP protein involved in m...
Table S7: Predicted critical multi-protein complexes and associated genes related to more than one
phenotype. Gene annotation was truncated for formatting purposes. Full annotation can be retrieve
using the SGD database.
20
Critical multi-protein complex stability and robustness
Are sensitive genes more conserved?
We have seen in the various analysis about gene conservation that only the dataset by Giaever et
al. (2002) and by Kastenmayer et al. (2006) seem different. Gene inducing a phenotype and over-
represented in some multi-protein complexes seem extremely well conserved across species. To assess
the results of our graphical approach, we perform a two samples t-test for every comparisons. Our null
hypothesis was that there is no difference between the mean evolutionary distances of the sensitive and
non-sensitive genes. Table S8 presents the results. At p-value ≤ 0.05, this analysis shows that only the
essential genes [1] and the sORFs [3] are different and well conserved across species. The null hypothesis
is true for the other experiments.
S.bayanus S.castellii S.kluyveri S.kudriavzevii S.mikatae S.paradoxus
essential 0.00 0.01 0.08 0.03 0.05 0.01
sORF 0.00 0.00 0.01 0.00 0.00 0.00
nystatin15 0.52 0.30 0.26 0.29 0.78 0.33
pH8g15 0.43 0.08 0.79 0.58 0.25 0.67
pH8g5 0.81 0.70 0.93 0.73 0.82 0.60
ypg15 0.33 0.53 0.33 0.30 0.87 0.22
CaCl2 0.60 0.45 0.40 0.41 0.20 0.46
cyclohex 0.34 0.80 0.82 0.53 0.40 0.23
FeLim 0.28 0.52 0.35 0.27 0.21 0.14
MPA 0.33 0.61 0.56 0.34 0.53 0.19
Paraq 0.29 0.49 0.21 0.51 0.21 0.11
YPGal 0.53 0.88 0.49 0.43 0.19 0.32
YPRaff 0.38 0.55 0.44 0.39 0.25 0.16
HU 0.48 0.76 0.87 0.45 0.61 0.56
YPGly 0.24 0.65 0.42 0.11 0.12 0.11
CAD 0.41 0.58 0.44 0.55 0.51 0.22
YPLac 0.25 0.70 0.42 0.20 0.20 0.11
UV 0.96 0.79 0.92 0.83 0.73 0.76
pH3 0.61 0.72 0.58 0.52 0.55 0.31
Table S8: Evolutionary distances not necessarily correlate with genes inducing a phenotype and their co-
membership in a protein complex. P-value of two sample t-tests between evolutionary distances of genes inducing
a phenotype and co-member of a complex and the other member of genes of the complex. Each column represent
the comparison between S. cerevisiae and the specified species. Each row is a different environmental condition.
The first 2 rows are the lethal phenotypes studied by Kastenmayer et al. (2006) (sORF: small Open Reading
Frames) and Giaever et al. (2002)(ESS: essentiality). The next 3 conditions were also tested by Giaever et al.
(2002) (nystatin: Nystatin (antifungal drug) after 5 and 15 generations; pH8: pH 8 (alkali stress) after 5 and 15
generations; ypg15: yeast/peptone/galactose 15 gen.). The remaining rows report the experimental conditions
studied by Dudley et al. (2005) (CaCl2: 0.7M calcium chloride, divalent cation; cyclohex: 0.18ug/ml cyclo-
heximide, protein synthesis; FeLim: iron limited,nutrient limited condition; MPA: 20ug/ml mycophenolic acid,
transcriptional elongation; Paraq: 1mM paraquat, oxidative stress; YPGal: 2YPRaff: 2HU: 11.4mg/ml Hu-
droxyurea, DNA replication and repair; YPGly: 3CAD: 55uM Cadmium, heavy metal; YPLac: 2UV: 100J/m2
ultra-violet, DNA replication and repair; pH3: low pH, general stress condition.)
Critical multi-protein complexes robustness
We proposed to make use of a synthetic lethal approach [15, 16] to further investigate the concept of
essentiality. To that aims, we selected 14 critical complexes that have not been much studied and for
which not all genes are essential (at least 2) (Table S9). We tested whether two or more deletions can
effectively disrupt the functioning of the complex and hence refine the role of the complex. We found
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that in those critical complexes
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In vivo experiment
gene1 gene2 score
apCompGavin2002: 14
ARX1 BUD20 1
ARX1 LHP1 1
ARX1 MRT4 0
BUD20 LHP1 1
BUD20 MRT4 1
LHP1 MRT4 1
apCompGavin2002: 49
LOC1 PUF6 E
MRT4 PUF6 E
LOC1 MRT4 1
apCompGavin2002: 181
FPR4 PUF6 0
PUF6 YER139C 1
ARX1 FPR4 0
ARX1 YER139C 1
FPR4 YER139C 0
apCompGavin2002: 22
PUF6 TIF4632 1
GAR1 PUF6 1
GAR1 TIF4632 0
apCompKrogan2004: 82 RPL8B RPS8A 0
apCompGavin2002: 182 NOP12 PUF6 1
apCompGavin2002: 41 PUF6 SSF1 1
apCompGavin2002: 158 NOP12 SSF1 0
apCompGavin2002: 75 MRPL10 SEC28 1
apCompHo2002: 73 PRB1 SEC28 1
apCompGavin2002: 50 ARX1 PUF6 1
apCompHo2002: 87 MSS116 NOP6 0
apCompGavin2002: 157 BRR1 STO1 1
apCompHo2002: Ho174 CKA1 CKB2 0
Table S9: The 27 pairs of non-essential genes tested for synthetic lethality interaction in not well studied but
probably essential protein complexes. The score column records the outcome of the experiment: 0 could not
create diploid, 1 no growth defect, E experimental error.
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KEGG pathways and phenotype
As described in the article, we computed the two omnibus tests to evaluate whether there is an over-
abundance of KEGG pathways with low or high proportions of genes associated with essentiality [1]
and haploinsuffiency [17]. The smoothed density estimates are shown in Figure S4 for essential genes,
Panel (a), and for haploinsufficient genes, Panel (b). These figures suggest that there are many more
pathways with zero genes in them than should be observed under the null hypothesis, suggesting that
the null hypothesis is not tenable for either the haploinsufficient genes or the essential genes.
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Figure S4: Essential and haploinsufficient genes not well represented in KEGG pathways.
Smoothed histograms of the proportion of genes per KEGG pathway that are associated to a phenotype.
The dark line represents the observed data and the light curves represent the permuted data. Only the
first 50 simulated density estimates out of 1000 permutations are displayed for visualization efficiency.
Panel (a) corresponds to the essential genes and Panel (b) to the haploinsufficient genes.
Using the graph theory approach [18], we observed the permutation results shown in Figure S5.
Panel (a) presents the results for essentiality and Panel (b) presents the results for haploinsufficiency.
In both cases the observed number of edges in the intersection is far larger than any value from the
permutations and hence the permutational p-value is less that 1 in 1,000 providing some evidence
against the null hypothesis and indicating that there is an association between the genes associated
with a particular phenotype and the KEGG pathways used in our analysis.
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Figure S5: Associations exist between KEGG pathways and the genes associated to essen-
tiality and haploinsufficiency. The distribution of the number of edges, under the null distribution
of genes randomly distributed (1,000 permutations), grey histogram, in KEGG pathways compared to
the number of observed edges, dashed red line. Panel (a) shows the results for the essential genes; Panel
(b) for the haploinsufficient genes.
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Since the overall tests provided some evidence against the null hypothesis the second part of the
analysis was performed and Hypergeometric tests were used to identify specific pathways that had an
over abundance of genes for each of the different phenotypes. Tables S10 and S11 present the KEGG
pathways having an overabundance of essential genes and haploinsufficient genes (p-value ≤ 0.01),
respectively.
Observed Expected Size Odds P.value Description
sce03050 28 8 32 20.01 1.02e−12 Proteasome
sce00563 20 5 21 55.90 6.53e−11 Glycosylphosphatidylinositol(GPI)-anchor biosynthesis
sce03022 21 6 23 29.41 1.55e−10 Basal transcription factors
sce03020 23 7 29 10.76 6.33e−09 RNA polymerase
sce04111 56 30 109 3.14 2.61e−08 Cell cycle - yeast
sce01031 18 5 21 16.62 3.33e−08 Glycan structures - biosynthesis 2
sce00240 37 19 70 3.19 3.45e−06 Pyrimidine metabolism
sce00970 21 10 37 3.62 1.39e−04 Aminoacyl-tRNA biosynthesis
sce04120 17 8 30 3.57 6.40e−04 Ubiquitin mediated proteolysis
sce03060 7 2 9 9.38 2.41e−03 Protein export
sce00100 12 5 21 3.60 3.82e−03 Biosynthesis of steroids
sce00230 36 24 89 1.88 4.28e−03 Purine metabolism
Table S10: KEGG pathways associated with Essentiality. KEGG and essential genes. KEGG identi-
fication number; Observed: number of essential genes in the pathway; Expected: number of essential
expected to be in the pathway; Odds: odds ratio; Size: total number of genes in the pathway; P-value:
p-value of Hypergeometric test that was used to identify whether or not some pathways have a significant
number of essential genes; Description: annotation given to the pathway.
Observed Expected Size Odds P-value Description
sce03010 73 11 148 48.02 1.33e−55 Ribosome
sce03020 7 2 29 3.98 5.28e−03 RNA polymerase
Table S11: KEGG pathways associated with Haploinsufficiency. KEGG in the interactome (all the
genes). KEGG identification number; Observed: number of haploinsufficient genes in the pathway;
Expected: number of haploinsufficient genes expected to be in the pathway; Odds: odds ratio; Size:
total number of genes in the pathway; P-value: p-value of Hypergeometric test that was used to iden-
tify whether or not some pathways have a significant number of haploinsufficient genes; Description:
annotation given to the pathway.
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